Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunogene therapy against mouse leukemia using B7 molecules.

T Takahashi1, N Hirano, T Takahashi

  • 1Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Cancer Gene Therapy
|March 4, 2000
PubMed
Summary

B7-2 costimulatory molecules are more effective than B7-1 at inducing antitumor immunity, contrary to some previous findings. This research highlights B7-2

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal and spatial distribution of DNA topoisomerase II alters during proliferation, differentiation, and apoptosis in HL-60 cells.

Blood·1998
Same author

Induction and inhibition of cytochrome P450 isoforms by imazalil, a food contaminant, in mouse small intestine and liver.

Xenobiotica; the fate of foreign compounds in biological systems·1998
Same author

Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.

Biochemical and biophysical research communications·1998
Same author

c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway.

Blood·1998
Same author

Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation.

British journal of haematology·1998
Same author

Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour.

Nature genetics·1998

Area of Science:

  • Immunology
  • Cancer Immunology
  • Molecular Biology

Background:

  • B7 costimulatory molecules (B7-1/CD80 and B7-2/CD86) are crucial for T-cell activation.
  • Tumor cells expressing B7 molecules can stimulate antitumor immunity, but the relative efficacy of B7-1 versus B7-2 is unclear.

Purpose of the Study:

  • To compare the efficiency of B7-1 and B7-2 in eliciting antitumor immunity.
  • To investigate the roles of different immune cells in B7-mediated antitumor responses.

Main Methods:

  • Engineered a mouse myelocytic leukemic cell line (8709) to express either B7-1 or B7-2.
  • Assessed the tumorigenicity and antitumor immunity induced by these engineered cell lines in syngeneic mice.
  • Utilized in vivo lymphocyte subset depletion to identify essential immune cells.

Related Experiment Videos

Main Results:

  • Both B7-1 and B7-2 expression reduced tumor formation.
  • Contrary to some reports, B7-2 expressing cells were superior to B7-1 expressing cells in inducing antitumor immunity.
  • Both CD4+ and CD8+ T cells were required for B7-mediated immunity, while natural killer cells were not essential.

Conclusions:

  • B7-2 can be more effective than B7-1 in eliciting antitumor immunity under certain conditions.
  • The findings challenge previous assumptions about the hierarchy of B7-1 and B7-2 function in antitumor responses.
  • CD4+ and CD8+ T cells are critical mediators of B7-dependent antitumor immunity.